N6-Methyladenine in Eukaryotic DNA: Tissue Distribution, Early Embryo Development, and Neuronal Toxicity
DNA methylation is one of the most important epigenetic modifications and is closely related with several biological processes such as regulation of gene transcription and the development of non-malignant diseases. The prevailing dogma states that DNA methylation in eukaryotes occurs essentially thr...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2021.657171/full |
id |
doaj-5d2ad1c45d704d998e841fab3b44a220 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sara B. Fernandes Sara B. Fernandes Nathalie Grova Nathalie Grova Sarah Roth Radu Corneliu Duca Radu Corneliu Duca Lode Godderis Lode Godderis Pauline Guebels Sophie B. Mériaux Andrew I. Lumley Pascaline Bouillaud-Kremarik Isabelle Ernens Yvan Devaux Henri Schroeder Jonathan D. Turner |
spellingShingle |
Sara B. Fernandes Sara B. Fernandes Nathalie Grova Nathalie Grova Sarah Roth Radu Corneliu Duca Radu Corneliu Duca Lode Godderis Lode Godderis Pauline Guebels Sophie B. Mériaux Andrew I. Lumley Pascaline Bouillaud-Kremarik Isabelle Ernens Yvan Devaux Henri Schroeder Jonathan D. Turner N6-Methyladenine in Eukaryotic DNA: Tissue Distribution, Early Embryo Development, and Neuronal Toxicity Frontiers in Genetics DNA methylation 6-methyladenine embryo development developmental neurotoxicity stress brain |
author_facet |
Sara B. Fernandes Sara B. Fernandes Nathalie Grova Nathalie Grova Sarah Roth Radu Corneliu Duca Radu Corneliu Duca Lode Godderis Lode Godderis Pauline Guebels Sophie B. Mériaux Andrew I. Lumley Pascaline Bouillaud-Kremarik Isabelle Ernens Yvan Devaux Henri Schroeder Jonathan D. Turner |
author_sort |
Sara B. Fernandes |
title |
N6-Methyladenine in Eukaryotic DNA: Tissue Distribution, Early Embryo Development, and Neuronal Toxicity |
title_short |
N6-Methyladenine in Eukaryotic DNA: Tissue Distribution, Early Embryo Development, and Neuronal Toxicity |
title_full |
N6-Methyladenine in Eukaryotic DNA: Tissue Distribution, Early Embryo Development, and Neuronal Toxicity |
title_fullStr |
N6-Methyladenine in Eukaryotic DNA: Tissue Distribution, Early Embryo Development, and Neuronal Toxicity |
title_full_unstemmed |
N6-Methyladenine in Eukaryotic DNA: Tissue Distribution, Early Embryo Development, and Neuronal Toxicity |
title_sort |
n6-methyladenine in eukaryotic dna: tissue distribution, early embryo development, and neuronal toxicity |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Genetics |
issn |
1664-8021 |
publishDate |
2021-05-01 |
description |
DNA methylation is one of the most important epigenetic modifications and is closely related with several biological processes such as regulation of gene transcription and the development of non-malignant diseases. The prevailing dogma states that DNA methylation in eukaryotes occurs essentially through 5-methylcytosine (5mC) but recently adenine methylation was also found to be present in eukaryotes. In mouse embryonic stem cells, 6-methyladenine (6mA) was associated with the repression and silencing of genes, particularly in the X-chromosome, known to play an important role in cell fate determination. Here, we have demonstrated that 6mA is a ubiquitous eukaryotic epigenetic modification that is put in place during epigenetically sensitive periods such as embryogenesis and fetal development. In somatic cells there are clear tissue specificity in 6mA levels, with the highest 6mA levels being observed in the brain. In zebrafish, during the first 120 h of embryo development, from a single pluripotent cell to an almost fully formed individual, 6mA levels steadily increase. An identical pattern was observed over embryonic days 7–21 in the mouse. Furthermore, exposure to a neurotoxic environmental pollutant during the same early life period may led to a decrease in the levels of this modification in female rats. The identification of the periods during which 6mA epigenetic marks are put in place increases our understanding of this mammalian epigenetic modification, and raises the possibility that it may be associated with developmental processes. |
topic |
DNA methylation 6-methyladenine embryo development developmental neurotoxicity stress brain |
url |
https://www.frontiersin.org/articles/10.3389/fgene.2021.657171/full |
work_keys_str_mv |
AT sarabfernandes n6methyladenineineukaryoticdnatissuedistributionearlyembryodevelopmentandneuronaltoxicity AT sarabfernandes n6methyladenineineukaryoticdnatissuedistributionearlyembryodevelopmentandneuronaltoxicity AT nathaliegrova n6methyladenineineukaryoticdnatissuedistributionearlyembryodevelopmentandneuronaltoxicity AT nathaliegrova n6methyladenineineukaryoticdnatissuedistributionearlyembryodevelopmentandneuronaltoxicity AT sarahroth n6methyladenineineukaryoticdnatissuedistributionearlyembryodevelopmentandneuronaltoxicity AT raducorneliuduca n6methyladenineineukaryoticdnatissuedistributionearlyembryodevelopmentandneuronaltoxicity AT raducorneliuduca n6methyladenineineukaryoticdnatissuedistributionearlyembryodevelopmentandneuronaltoxicity AT lodegodderis n6methyladenineineukaryoticdnatissuedistributionearlyembryodevelopmentandneuronaltoxicity AT lodegodderis n6methyladenineineukaryoticdnatissuedistributionearlyembryodevelopmentandneuronaltoxicity AT paulineguebels n6methyladenineineukaryoticdnatissuedistributionearlyembryodevelopmentandneuronaltoxicity AT sophiebmeriaux n6methyladenineineukaryoticdnatissuedistributionearlyembryodevelopmentandneuronaltoxicity AT andrewilumley n6methyladenineineukaryoticdnatissuedistributionearlyembryodevelopmentandneuronaltoxicity AT pascalinebouillaudkremarik n6methyladenineineukaryoticdnatissuedistributionearlyembryodevelopmentandneuronaltoxicity AT isabelleernens n6methyladenineineukaryoticdnatissuedistributionearlyembryodevelopmentandneuronaltoxicity AT yvandevaux n6methyladenineineukaryoticdnatissuedistributionearlyembryodevelopmentandneuronaltoxicity AT henrischroeder n6methyladenineineukaryoticdnatissuedistributionearlyembryodevelopmentandneuronaltoxicity AT jonathandturner n6methyladenineineukaryoticdnatissuedistributionearlyembryodevelopmentandneuronaltoxicity |
_version_ |
1721428767818121216 |
spelling |
doaj-5d2ad1c45d704d998e841fab3b44a2202021-05-24T06:13:30ZengFrontiers Media S.A.Frontiers in Genetics1664-80212021-05-011210.3389/fgene.2021.657171657171N6-Methyladenine in Eukaryotic DNA: Tissue Distribution, Early Embryo Development, and Neuronal ToxicitySara B. Fernandes0Sara B. Fernandes1Nathalie Grova2Nathalie Grova3Sarah Roth4Radu Corneliu Duca5Radu Corneliu Duca6Lode Godderis7Lode Godderis8Pauline Guebels9Sophie B. Mériaux10Andrew I. Lumley11Pascaline Bouillaud-Kremarik12Isabelle Ernens13Yvan Devaux14Henri Schroeder15Jonathan D. Turner16Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, LuxembourgFaculty of Science, Technology and Medicine, University of Luxembourg, Belval, LuxembourgImmune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, LuxembourgCalbinotox, EA7488, Faculty of Science and Technology, University of Lorraine, Vandoeuvre-lès-Nancy, FranceImmune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, LuxembourgUnit Environmental Hygiene and Human Biological Monitoring, Department of Health Protection, National Health Laboratory (LNS), Dudelange, LuxembourgCentre for Environment and Health, Department of Public Health and Primary Care, KU Leuven, Leuven, BelgiumCentre for Environment and Health, Department of Public Health and Primary Care, KU Leuven, Leuven, BelgiumIDEWE, External Service for Prevention and Protection at Work, Heverlee, BelgiumImmune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, LuxembourgImmune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, LuxembourgCardiovascular Research Unit, Department of Public Health, Luxembourg Institute of Health, Strassen, LuxembourgCalbinotox, EA7488, Faculty of Science and Technology, University of Lorraine, Vandoeuvre-lès-Nancy, FranceCardiovascular Research Unit, Department of Public Health, Luxembourg Institute of Health, Strassen, LuxembourgCardiovascular Research Unit, Department of Public Health, Luxembourg Institute of Health, Strassen, LuxembourgCalbinotox, EA7488, Faculty of Science and Technology, University of Lorraine, Vandoeuvre-lès-Nancy, FranceImmune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, LuxembourgDNA methylation is one of the most important epigenetic modifications and is closely related with several biological processes such as regulation of gene transcription and the development of non-malignant diseases. The prevailing dogma states that DNA methylation in eukaryotes occurs essentially through 5-methylcytosine (5mC) but recently adenine methylation was also found to be present in eukaryotes. In mouse embryonic stem cells, 6-methyladenine (6mA) was associated with the repression and silencing of genes, particularly in the X-chromosome, known to play an important role in cell fate determination. Here, we have demonstrated that 6mA is a ubiquitous eukaryotic epigenetic modification that is put in place during epigenetically sensitive periods such as embryogenesis and fetal development. In somatic cells there are clear tissue specificity in 6mA levels, with the highest 6mA levels being observed in the brain. In zebrafish, during the first 120 h of embryo development, from a single pluripotent cell to an almost fully formed individual, 6mA levels steadily increase. An identical pattern was observed over embryonic days 7–21 in the mouse. Furthermore, exposure to a neurotoxic environmental pollutant during the same early life period may led to a decrease in the levels of this modification in female rats. The identification of the periods during which 6mA epigenetic marks are put in place increases our understanding of this mammalian epigenetic modification, and raises the possibility that it may be associated with developmental processes.https://www.frontiersin.org/articles/10.3389/fgene.2021.657171/fullDNA methylation6-methyladenineembryo developmentdevelopmental neurotoxicitystressbrain |